APA

Mercer L. K., Davies R., Galloway J. B., Low A., Lunt M., Dixon W. G., Watson K. D., Symmons D. P. M. & Hyrich K. L. (20130226). Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. : Rheumatology (Oxford, England).

Chicago

Mercer Louise K, Davies Rebecca, Galloway James B, Low Audrey, Lunt Mark, Dixon William G, Watson Kath D, Symmons Deborah P M and Hyrich Kimme L. 20130226. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. : Rheumatology (Oxford, England).

Harvard

Mercer L. K., Davies R., Galloway J. B., Low A., Lunt M., Dixon W. G., Watson K. D., Symmons D. P. M. and Hyrich K. L. (20130226). Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. : Rheumatology (Oxford, England).

MLA

Mercer Louise K, Davies Rebecca, Galloway James B, Low Audrey, Lunt Mark, Dixon William G, Watson Kath D, Symmons Deborah P M and Hyrich Kimme L. Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population. : Rheumatology (Oxford, England). 20130226.